Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hi-MAM Study: Treatment of High-Risk Moderate Acute Malnutrition
NCT03647150Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amoxicillin in acute malnutrition (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Recovery from moderate acute malnutrition (MAM) up to 12 weeks. Started Nov 2018; status: completed.
02
Drugs
amoxicillin
03
Conditions
acute malnutrition
Beyond the preview
Go deeper on NCT03647150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03647150.